Status:
COMPLETED
Exercise Induced Bronchoconstriction and Field Tests
Lead Sponsor:
Karolinska Institutet
Collaborating Sponsors:
Olympiatoppen, The Norwegian Olympic Sports Centre, Oslo, Norway
Norwegian School of Sport Sciences
Conditions:
Exercise Induced Bronchoconstriction
Asthma
Eligibility:
All Genders
16-50 years
Phase:
NA
Brief Summary
Asthma and exercise induced bronchoconstriction (EIB) represent an important challenge for the athlete, and correct diagnosis is important as it affects health as well as performance with strict regul...
Detailed Description
Asthma is the most common chronic condition in Olympic athletes. Asthma is defined as a chronic inflammation in the airways associated with bronchial hyper responsiveness (BHR). It is suggested that t...
Eligibility Criteria
Inclusion
- History of EIB symptoms within the last 8 weeks will be invited to participate
Exclusion
- Additional asthma treatment until completion of the study.
- Athletes will be excluded if any of following criterion is fulfilled; FEV1 \<75%, a forced vital capacity \<80%, a recent course of oral corticosteroids or infections, as well as pregnancy, chronic diseases or inability to perform the study procedures.
Key Trial Info
Start Date :
December 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04275648
Start Date
December 1 2020
End Date
December 30 2021
Last Update
August 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Olympiatoppen
Oslo, Norway